On clinical trial fragility due to patients lost to follow up
Abstract Background Clinical trials routinely have patients lost to follow up. We propose a methodology to understand their possible effect on the results of statistical tests by altering the concept of the fragility index to treat the outcomes of observed patients as fixed but incorporate the poten...
Enregistré dans:
Auteurs principaux: | Benjamin R. Baer, Stephen E. Fremes, Mario Gaudino, Mary Charlson, Martin T. Wells |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bf76edffb4524432be3b3cc45054d90e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fragility Index as a Measure of Randomized Clinical Trial Quality in Adult Reconstruction: A Systematic Review
par: Carl L. Herndon, MD, et autres
Publié: (2021) -
Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
par: Maria Vargas, et autres
Publié: (2021) -
Incidence and Predictors of Loss to Follow-Up Among Children Attending ART Clinics in Northeast Ethiopia: A Retrospective Cohort Study
par: Menshw T, et autres
Publié: (2021) -
Melanoma: Staging and Follow-Up
par: Chryssoula Papageorgiou, et autres
Publié: (2021) -
Time Until Loss to Follow-Up, Incidence, and Predictors Among Adults Taking ART at Public Hospitals in Southern Ethiopia
par: Dessu S, et autres
Publié: (2021)